← Dashboard
Stock
LLY
ELI LILLY & CoHealth CarePharmaceuticalsLatest close $10659 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
9
27 funds tracked
Ever held
15
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Nov 13, 2013Feb 13, 2019Feb 14, 2024Feb 13, 2026
Now
9
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q4 2013 | 51Q | $40 | $1065 | +2561% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $919 | $1065 | +16% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $919 | $1065 | +16% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $919 | $1065 | +16% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $919 | $1065 | +16% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $919 | $1065 | +16% |
| Renaissance Technologies re-entered | Q4 2024(8Q snapshot) | 6Q | $802 | $1065 | +33% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $776 | $1065 | +37% |
| Soros Fund Management re-entered | Q1 2025(8Q snapshot) | 5Q | $837 | $1065 | +27% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Tiger Global | Q3 2023 | Q4 2025 | → $1022 | +94% |
| Coatue Management | Q3 2023 | Q4 2025 | → $1022 | +94% |
| Viking Global Investors 4× in & out | Q3 2025 | Q4 2025 | → $1022 | +50% |
| Maverick Capital 4× in & out | Q3 2025 | Q4 2025 | → $1022 | +50% |
| Duquesne Family Office 2× in & out | Q1 2025 | Q4 2025 | → $1022 | +22% |
| Lone Pine Capital | Q1 2025 | Q3 2025 | → $680 | -19% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at ELI LILLY & Co. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
9
Filings · last 90d
22
Total on file
693
Recent SEC buffer
Most recent
May 19, 2026
30d / 90d windows measured from May 19, 2026 — the most recent Form 4 on file — not from today.
- Form 40001262388-26-000010May 19, 2026
- Form 40000059478-26-000055May 19, 2026
- Form 40000059478-26-000053May 19, 2026
- Form 40001310215-26-000008May 19, 2026
- Form 40000316011-26-000015May 7, 2026
- Form 40001262388-26-000008Apr 21, 2026
- Form 40000059478-26-000038Apr 21, 2026
- Form 40000059478-26-000036Apr 21, 2026
- Form 40000059478-26-000034Apr 21, 2026
- Form 40001262388-26-000006Mar 17, 2026
- Form 40000059478-26-000025Mar 17, 2026
- Form 40000059478-26-000023Mar 17, 2026
- Form 40001310215-26-000006Mar 17, 2026
- Form 40001955972-26-000006Feb 19, 2026
- Form 40001262388-26-000004Feb 18, 2026
Showing 15 of 693 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · ELI LILLY & CoAnnual figures sourced directly from ELI LILLY & Co's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$65.18B
FY2025+45% YoY
Net income
$20.64B
FY2025+95% YoY
EPS (diluted)
$22.95
FY2025+96% YoY
Free cash flow(?)
$16.81B
FY2025+91% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for ELI LILLY & Co — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 20, 2026
- 8-KMaterial eventMay 7, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- DEF 14AProxy statementMar 20, 2026
- 10-KAnnual reportFeb 12, 2026
- 8-KMaterial eventFeb 4, 2026
- 8-KMaterial eventNov 21, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 30, 2025
- 8-KMaterial eventAug 20, 2025
- 10-QQuarterly reportAug 7, 2025
- 8-KMaterial eventAug 7, 2025
- 8-KMaterial eventMay 8, 2025
- 10-QQuarterly reportMay 1, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Soros Fund Management | Q1 2026 | open | $1038 | $988 | -5% |
| Renaissance Technologies | Q1 2026 | open | $1035 | $988 | -5% |
| Bridgewater Associates | Q4 2025 | open | $1018 | $1065 | +5% |
| Viking Global Investors | Q3 2025 | Q4 2025 | $680 | $1022 | +50% |
| Maverick Capital | Q3 2025 | Q4 2025 | $680 | $1022 | +50% |
| Point72 Asset Management | Q2 2025 | open | $727 | $988 | +36% |
| Soros Fund Management | Q1 2025 | Q2 2025 | $837 | $727 | -13% |
| Lone Pine Capital | Q1 2025 | Q3 2025 | $837 | $680 | -19% |
| Duquesne Family Office | Q1 2025 | Q4 2025 | $837 | $1022 | +22% |
| Point72 Asset Management | Q4 2024 | Q1 2025 | $776 | $837 | +8% |
| Renaissance Technologies | Q4 2024 | Q4 2025 | $802 | $1018 | +27% |
| Citadel Advisors | Q3 2024 | open | $919 | $988 | +8% |
| Two Sigma Investments | Q3 2024 | open | $919 | $988 | +8% |
| D.E. Shaw | Q3 2024 | open | $919 | $988 | +8% |
| AQR Capital Management | Q3 2024 | open | $919 | $988 | +8% |
| Millennium Management | Q3 2024 | open | $919 | $988 | +8% |
| Viking Global Investors | Q1 2024 | Q1 2025 | $746 | $837 | +12% |
| Maverick Capital | Q4 2023 | Q2 2024 | $600 | $776 | +29% |
| Tiger Global | Q3 2023 | Q4 2025 | $528 | $1022 | +94% |
| Coatue Management | Q3 2023 | Q4 2025 | $528 | $1022 | +94% |
| Duquesne Family Office | Q3 2022 | Q3 2024 | $305 | $919 | +202% |
| Maverick Capital | Q3 2021 | Q1 2022 | $258 | $226 | -12% |
| Bridgewater Associates | Q3 2021 | Q3 2025 | $253 | $656 | +159% |
| Maverick Capital | Q4 2020 | Q1 2021 | $133 | $195 | +47% |
| Bridgewater Associates | Q2 2020 | Q3 2020 | $148 | $143 | -4% |
| Bridgewater Associates | Q4 2019 | Q1 2020 | $104 | $132 | +27% |
| Bridgewater Associates | Q1 2018 | Q1 2019 | $67 | $108 | +61% |
| Bridgewater Associates | Q3 2017 | Q4 2017 | $72 | $73 | +2% |
| Viking Global Investors | Q2 2016 | Q1 2017 | $67 | $68 | +3% |
| Bridgewater Associates | Q1 2016 | Q2 2017 | $60 | $70 | +16% |
| Viking Global Investors | Q2 2015 | Q3 2015 | $60 | $70 | +16% |
| Bridgewater Associates | Q1 2015 | Q2 2015 | $58 | $61 | +5% |
| Bridgewater Associates | Q4 2013 | Q3 2014 | $40 | $49 | +24% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.